No such message found

patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: allo- YF

allo_geneic•10 hours agoFlag

Pluristem's Institutional Ownership As of November 1st, 2013 ! Much, Much Larger Now !

INSTITUTION NAME - SHARES HELD
Migdal Mutual Funds Ltd. 399,739
Clal Finance Mutual Funds Ltd. 211,208
J.P.Morgan Securities Inc. 170,375
I.B.I Mutual Funds Management Ltd 125,749
Ayalon Mutual Funds Ltd. 114,999
DS Mutual Funds Ltd. 107,985
Meitav DS Mutual Funds Ltd 96,970
Susquehanna Financial Group, LLLP 56,247
Psagot Mutual Funds Ltd. 45,739
Oppenheimer & Co. Inc. 35,450
FirmInvest AG 25,000
Van Eck Associates Corporation 24,181
Epsilon Mutual Funds Mgmt (1991) Ltd 20,883
Tower Research Capital LLC 20,080
Psagot Investment House Ltd. 17,000
Migdal Selected Biomed 178,240
Harel Selected BioMed 166,208
Alfa Platinum Tel Aviv 100 114,479
IBI Tel Aviv 75 Basket 108,683
Meitav DS Advised Flexible 107,985
Migdal Tel Aviv 75 Tracker 79,760
Migdal Tel Aviv 100 Tracker 73,339
Meitav Global Shares 50,000
Harel Tel Aviv 75 45,000
Psagot YETER 31,408
CP Global BioPharma 25,000
Meitav YETER 22,000
Market Vectors Israel ETF 21,179
Epsilon Equity 20,883
Pitango General Equity 15,661 Less

Share
New Message
Please login to post a reply